Fig. 2
From: Identification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
Correlations of serum β-catenin levels with HBV DNA in HBV-related liver diseases. a–c Distribution of serum β-catenin levels in CHB (a), HBLC (b) and HCC (c) patients with different viral load (< 5, ≥ 5–7 and ≥ 7 log10 IU/mL). d–f Correlation between serum β-catenin levels and HBV DNA levels in CHB (d), HBLC (e) and HCC (f) patients. Data represents the mean ± SD, Ns no statistical significance